Category: Publications

Pharmacovigilance: a crucial issue for the health and safety of all Europeans

Pharmacovigilance in Europe: the European Commission’s proposals endanger the population


A series of public health disasters (from thalidomide in the 1960s to rofecoxib (Vioxx°) at the beginning of this century) have served to remind us of the crucial nature of pharmacovigilance. To this end, the European Commission’s proposed legislative changes represent a serious regression in the protection of European citizens.